FindTrial
Sign In

Expanded Access to NanoDoce

Expanded Access to NanoDoce

Status
NO_LONGER_AVAILABLE
Phases
Unknown
Study type
Expanded Access
Source
ClinicalTrials.gov
Registry ID
NCT04060628
Enrollment
Unknown
Registered
2019-08-19
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urogenital Neoplasms

Brief summary

NanOlogy may consider offering expanded access to NanoDoce for patients who do not meet the enrollment criteria of clinical trials in progress.

Interventions

DRUGNanoDoce (sterile nanoparticulate docetaxel) Powder for Suspension

Sponsors

NanOlogy, LLC
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
ALL

Inclusion criteria

\-

Exclusion criteria

\-

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026